Haemophilus influenzae type b: disease and immunity in humans.
D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial; D001770:Blood Bactericidal Activity; D002675:Child, Preschool; D003429:Cross Reactions; D004825:Epiglottis / Q000276:immunology / Q000382:microbiology; D004926:Escherichia coli / Q000276:immunology; D006192:Haemophilus Infections / Q000276:immunology*; D006193:Haemophilus influenzae / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D007818:Laryngeal Diseases / Q000276:immunology; D008583:Meningitis, Haemophilus / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D011135:Polysaccharides, Bacterial; D011817:Rabbits; D014481:United States
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006649:Histocompatibility Antigens; D011135:Polysaccharides, Bacterial